Loading…
Endothelial permeability is increased by the supernatant of peripheral blood mononuclear cells stimulated with HLA Class II antibody
BACKGROUND: The generation of inflammatory mediators from monocytes activated by HLA Class II antibodies is thought to play important roles in the etiology of nonhemolytic transfusion reactions. Increased permeability of endothelial cells contributes to the pathogenesis of rash, urticaria, angioedem...
Saved in:
Published in: | Transfusion (Philadelphia, Pa.) Pa.), 2008-10, Vol.48 (10), p.2060-2068 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | BACKGROUND: The generation of inflammatory mediators from monocytes activated by HLA Class II antibodies is thought to play important roles in the etiology of nonhemolytic transfusion reactions. Increased permeability of endothelial cells contributes to the pathogenesis of rash, urticaria, angioedema, and pulmonary edema, which are symptoms of transfusion reactions.
STUDY DESIGN AND METHODS: We investigated whether inflammatory mediators released from monocytes upon stimulation by HLA Class II antibodies could increase endothelial permeability. Human endothelial cell monolayers were incubated with cell‐free supernatants of peripheral blood mononuclear cells (PBMNCs) stimulated with HLA Class II antibody–containing plasma (anti‐HLA‐DR plasma), which has been implicated in severe nonhemolytic transfusion reactions. The permeability of endothelial cells to dextran was measured.
RESULTS: The supernatants of PBMNCs stimulated with the anti‐HLA‐DR plasma in corresponding antigen‐antibody combinations were able to increase endothelial permeability. At least 3 hours of exposure of PBMNCs to anti‐HLA‐DR plasma was required to produce a supernatant that could induce a significant increase in permeability. Simultaneous addition of tumor necrosis factor α (TNF‐α) and interleukin 1β (IL‐1β) neutralizing antibodies to the activated PBMNC supernatant significantly reduced the increase in permeability. Treatment of the endothelial cells with an inhibitor of nuclear factor κB (NF‐κB), but not inhibitors of apoptosis, significantly prevented the increase in permeability.
CONCLUSION: Both TNF‐α and IL‐1β, generated from PBMNCs by anti‐HLA‐DR plasma in a corresponding antigen‐antibody–dependent manner, led to an increase in endothelial permeability. The activation of monocytes by the HLA‐DR antibodies and the resultant inflammatory mediators could contribute to the pathogenesis of rash, urticaria, angioedema, and pulmonary edema after transfusion. |
---|---|
ISSN: | 0041-1132 1537-2995 |
DOI: | 10.1111/j.1537-2995.2008.01809.x |